Man Takes Sleep Meds Before Bed—What He Wakes Up to Unlocks ‘New Fear’
A doctor shared the scary story of what happened when he took his sleep medicine before bed, and…
Unraveling resistance at single-cell resolution
HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted…
Osteoprotegerin links bone metabolism to cardiovascular disease
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Osteoprotegerin (OPG), a glycoprotein in the tumor…
Nanovaccine design boosts immune attack on HPV tumors
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity
In recent years, cancer researchers have made major breakthroughs by using the body’s immune system to fight cancer.…
Gut microbiome may be a central player in the body’s response to cancer
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from…
Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer
Dec 26 2025 A new study published today in Science Translational Medicine by researchers at The University of…
Reframing the role of MCL1 in cancer signaling and metabolism
A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD…
Bifunctional biomaterials for postoperative management of osteosarcoma
Background Osteosarcoma is the most prevalent primary malignant bone tumor in children and adolescents. The current standard treatment…
AI uncovers how DNA architecture failures trigger blood cancer
Cancer isn’t just about broken genes-it’s about broken architecture. Imagine a city where roads suddenly vanish, cutting off…
AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancer
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification…